The present invention pertains to a composition for enhancing the production rates of neutralizing antibodies, the composition containing a healthy extract as an active ingredient. In an animal model inoculated with a vaccine after the administration of the healthy extract of the present invention, there are the effects in which the formation of antigen-specific antibodies is enhanced, the production rate of cytokine produced by antigen stimulation, which has been lowered by anticancer drugs, is restored, and the production rates of antibodies to H1N1 and H3N2 antigens are enhanced after vaccination. Thus, applying the composition of the present invention to immunocompromised patients or the elderly prior to flu vaccination is expected to increase the production rate of antibodies.La présente invention concerne une composition pour le taux de production d'anticorps neutralisants, la composition contenant un extrait saint en tant que principe actif. Dans un modèle animal inoculé avec un vaccin après l'administration de l'extrait sain de la présente invention, il existe des effets dans lesquels la formation d'anticorps spécifiques d'antigène est améliorée, le taux de production de cytokine produit par stimulation d'antigène, qui a été abaissé par des médicaments anticancéreux, est rétabli, et les taux de production d'anticorps contre les antigènes H1N1 et H3N2 sont améliorés après vaccination. Ainsi, l'application de la composition de la présente invention à des patients immunodéprimés ou aux personnes âgées avant la vaccination contre la grippe est attendue pour augmenter le taux de production d'anticorps.본 발명은 건강 추출물을 유효성분으로 포함하는 중화항체 생성율 증진용 조성물에 관한 것으로, 본 발명의 건강 추출물을 투여한 후, 백신을 접종한 동물모델은 항원 특이 항체 형성이 증진되었고, 항암제에 의해 저하되었던 항원 자극에 의해 생성되는 사이토카인의 생성 비율이 회복되며, 백신 접종 후, H1N1 및 H3N2 항원에 대한 항체 생성율이 증진되는 효과가 있으므로, 본 발명의 조성물을 독감백신 접종 전에 면역력인 낮아진 환자 또는 노인들에게 적용하면 항체 생성율을 증진시킬 수 있을 것으로 기대된다.
